Cullinan Therapeutics, Inc. (NASDAQ: CGEM), a biotechnology firm headquartered in Cambridge, Massachusetts, is capturing investor attention with a staggering potential upside of 249.45%. Specializing in developing innovative therapies for autoimmune..
Butterfly Network, Inc. (NASDAQ: BFLY) stands out in the healthcare sector with its innovative approach to medical imaging, offering handheld ultrasound devices that integrate directly with everyday technology. While the..
Immatics N.V. (NASDAQ: IMTX) stands at an intriguing intersection of innovation and opportunity within the biotechnology sector. This German-based biopharmaceutical company is making significant strides in cancer treatment through its..
Ginkgo Bioworks Holdings, Inc. (NYSE: DNA), a key player in the biotechnology sector, has captured investor attention with its ambitious approach to cell programming. Despite the current market headwinds, Ginkgo’s..
Weave Communications, Inc. (NASDAQ: WEAV) is making waves in the healthcare sector with its innovative customer experience and payments software platform tailored for small and medium-sized healthcare businesses across the..
Sana Biotechnology, Inc. (NASDAQ: SANA) is positioning itself as a promising player in the healthcare sector, specifically within biotechnology. With a market capitalization of $451.11 million, the Seattle-based company is..
Fulgent Genetics, Inc. (NASDAQ: FLGT), a prominent player in the healthcare sector, specifically within the diagnostics and research industry, presents a fascinating case for investors seeking potential growth opportunities. With..
AbCellera Biologics Inc. (NASDAQ: ABCL), a Canadian biotechnology firm, is capturing investor attention with a compelling potential upside of 321.43%. As a key player in the healthcare sector, AbCellera focuses..
Simulations Plus, Inc. (NASDAQ: SLP) has long been a significant player in the healthcare sector, specifically within the health information services industry. Headquartered in Lancaster, California, this company is renowned..
Oculis Holding AG (OCS), a Swiss-based biotechnology firm, is capturing the attention of investors with its promising clinical-stage drug candidates and an impressive potential upside of 84.08%. With a current..
Akebia Therapeutics, Inc. (NASDAQ: AKBA) is making waves in the healthcare sector with its innovative approach to treating kidney diseases. Headquartered in Cambridge, Massachusetts, this biopharmaceutical company is poised for..
CorMedix Inc. (NASDAQ: CRMD), a biopharmaceutical player in the healthcare sector, is making waves with its lead product candidate, DefenCath. Designed to tackle the critical issue of catheter-related bloodstream infections..
NeuroPace, Inc. (NASDAQ: NPCE), a prominent player in the medical devices sector focusing on innovative treatments for drug-resistant focal epilepsy, is capturing attention with its strong buy ratings from analysts...
Regulus Therapeutics Inc. (RGLS), a cutting-edge player in the biotechnology sector, is capturing investor attention with an enticing potential upside of 11.25%. This clinical-stage biopharmaceutical company, focused on pioneering microRNA-targeted..
Owens & Minor, Inc. (NYSE: OMI) presents a compelling case for investors seeking opportunities within the healthcare sector. With a market capitalization of $527.1 million, this medical distribution company operates..
For investors with an eye on the healthcare sector, Arvinas, Inc. (NASDAQ: ARVN) presents an intriguing opportunity. With a market capitalization of $472.25 million, this biotechnology company is making waves..
For individual investors with an eye on the biotechnology sector, Stoke Therapeutics, Inc. (NASDAQ: STOK) presents an intriguing opportunity. This early-stage biopharmaceutical company, with a current market cap of $518.67..
Akso Health Group (NASDAQ: AHG) is capturing significant attention within the healthcare sector, primarily due to its impressive 676% revenue growth. Operating from Qingdao, China, Akso Health Group has carved..
Spyre Therapeutics, Inc. (NASDAQ: SYRE), a biotech company headquartered in Waltham, Massachusetts, has captured the attention of investors with its promising pipeline of treatments for inflammatory bowel disease (IBD). With..
Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), a pioneering biopharmaceutical company, stands at the forefront of innovation in treating brain health disorders. Based in New York, this clinical-stage company is capturing..
